Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)

NCT05001698 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca